Cited by 42Neuroendocrine regulation and behaviorSchizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior

Oxytocin as a potential therapeutic target for schizophrenia and other neuropsychiatric conditions

Open access
Feifel, David·2012·Neuropsychopharmacology

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/npp.2011.184

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK (2008). Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 65: 220-231. Neuropsychopharmacology Reviews (2012) 37, 303-304; doi:10.1038/npp.2011.244 ..................................................................... · DOI

Cited by

Sorted by citations

Authors
Feifel, D.
Affiliations
University of California San Diego (US)
Corresponding author
Feifel, David
Venue
Neuropsychopharmacology
Published
2011-12-13
Volume
37
Issue
1
Pages
304-305
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W1973277030
Cited by
42
References
6
Citations by year
2024: 1 · 2023: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 9 · 2015: 6 · 2014: 9 · 2013: 7 · 2012: 1
FWCI
7.42
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
oxytocin, schizophrenia, intranasal administration, adjunctive therapy, antipsychotic drugs, positive and negative symptoms, verbal memory, prosocial behavior, endogenous oxytocin, plasma oxytocin, autism spectrum disorder, social anxiety disorder, neuropsychiatric disorders, therapeutic target, placebo-controlled crossover trial, cognitive function, social cognition, neuroendocrine regulation, hypothalamic-pituitary-adrenal axis
MeSH terms
Mental Disorders, Humans, Oxytocics, Oxytocin, Psychopharmacology, Schizophrenia, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review